Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2020

Ausgabe 2/2020

Inhaltsverzeichnis ( 26 Artikel )

11.10.2019 | Editorial | Ausgabe 2/2020

Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction

Kassandra P. Nealon, Nikhil Sobti, Michele Gadd, Michelle Specht, Eric C. Liao

12.10.2019 | Review | Ausgabe 2/2020

Microtubule-associated tumor suppressors as prognostic biomarkers in breast cancer

Sylvie Rodrigues-Ferreira, Angie Molina, Clara Nahmias

12.10.2019 | Review | Ausgabe 2/2020

Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials

Xiaoying Qian, Zhian Li, GuoDong Ruan, Chuanjian Tu, Wu Ding

23.10.2019 | Review | Ausgabe 2/2020

Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment

A. S. Komorowski, R. C. Pezo

29.10.2019 | Review | Ausgabe 2/2020

Increased expression of P-cadherin is an indicator of poor prognosis in breast cancer: a systematic review and meta-analysis

Sriya Sridhar, Christabelle Rajesh, Padacherri Vethil Jishnu, Pradyumna Jayaram, Shama Prasada Kabekkodu

23.10.2019 | Preclinical Study | Ausgabe 2/2020

Risk stratification system for groups with a low, intermediate, and high risk of subsequent distant metastasis and death following isolated locoregional recurrence of breast cancer

Young Joo Lee, Heeseung Park, Cheol Min Kang, Sung-chan Gwark, Sae Byul Lee, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Sung-Bae Kim, Seung Do Ahn, Gyungyub Gong, Byung Ho Son, Sei-Hyun Ahn, Jong Won Lee

24.10.2019 | Preclinical study | Ausgabe 2/2020 Open Access

Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment

Radoslaw Bednarek, Anna Selmi, Dagmara Wojkowska, Kamil Karolczak, Marcin Popielarski, Marta Stasiak, Moro O. Salifu, Anna Babinska, Maria Swiatkowska

26.10.2019 | Preclinical study | Ausgabe 2/2020

Molecular determinants of drug response in TNBC cell lines

Nathan M. Merrill, Eric J. Lachacz, Nathalie M. Vandecan, Peter J. Ulintz, Liwei Bao, John P. Lloyd, Joel A. Yates, Aki Morikawa, Sofia D. Merajver, Matthew B. Soellner

02.11.2019 | Preclinical study | Ausgabe 2/2020 Open Access

Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer

Yousif A. Kariri, Chitra Joseph, Sasagu Kurozumi, Michael S. Toss, Mansour Alsaleem, Sara Raafat, Nigel P. Mongan, Mohammed A. Aleskandarany, Andrew R. Green, Emad A. Rakha

04.11.2019 | Preclinical study | Ausgabe 2/2020

Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast

Debarpan Mitra, Sayantan Bhattacharyya, Neyaz Alam, Sagar Sen, Saunak Mitra, Syamsundar Mandal, Shivani Vignesh, Biswanath Majumder, Nabendu Murmu

14.10.2019 | Clinical Trial | Ausgabe 2/2020

Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients

Hugo Herrscher, Michel Velten, Julie Leblanc, Michal Kalish-Weindling, Cathie Fischbach, Delphine Exinger, Xavier Pivot, Thierry Petit

14.10.2019 | Clinical trial | Ausgabe 2/2020

The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study

Donna L. Berry, Traci M. Blonquist, Barbara Halpenny, Fangxin Hong, Samantha C. Morrison-Ma, Michele C. McCullough, Katherine Carelli, Laura S. Dominici, Tari A. King

16.10.2019 | Clinical trial | Ausgabe 2/2020

Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies

Dimitri Carene, Alicia Tran-Dien, Jérôme Lemonnier, Florence Dalenc, Christelle Levy, Jean-Yves Pierga, William Jacot, Jean-Luc Canon, Catherine Richon, Ludovic Lacroix, Christophe Caux, Fabrice André, Stefan Michiels

23.10.2019 | Clinical trial | Ausgabe 2/2020

Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients

Malgorzata Banys-Paluchowski, Karin Milde-Langosch, Tanja Fehm, Isabell Witzel, Leticia Oliveira-Ferrer, Barbara Schmalfeldt, Volkmar Müller

24.10.2019 | Clinical trial | Ausgabe 2/2020

Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines?

Youngjee Choi, Katherine C. Smith, Aishwarya Shukla, Amanda L. Blackford, Antonio C. Wolff, Elissa Thorner, Kimberly S. Peairs, Walid El Ayass, Patricia Njoku, Katie Papathakis, Carol D. Riley, Nelli Zafman, Fariba Asrari, Melissa Camp, Jean L. Wright, Nancy J. Mayonado, Sharon M. White, Claire F. Snyder

25.10.2019 | Clinical trial | Ausgabe 2/2020

Efficacy of intraoperative specimen radiography as margin assessment tool in breast conserving surgery

Annika Funk, Jörg Heil, Aba Harcos, Christina Gomez, Anne Stieber, Hans Junkermann, André Hennigs, Geraldine Rauch, H.-P. Sinn, Fabian Riedel, Benedikt Schäfgen, Sarah Hug, Anna Maier, Maria Blumenstein, Christoph Domschke, Sarah Schott, Markus Wallwiener, Joachim Rom, Florian Schütz, Christof Sohn, Michael Golatta

16.10.2019 | Epidemiology | Ausgabe 2/2020

Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer

Toshiaki Iwase, Takafumi Sangai, Hiroshi Fujimoto, Yuji Sawabe, Kazuyuki Matsushita, Kengo Nagashima, Yasunori Sato, Ayako Nakagawa, Takahito Masuda, Takeshi Nagashima, Masayuki Ohtsuka

17.10.2019 | Epidemiology | Ausgabe 2/2020

Association of lifestyle and clinical characteristics with receipt of radiotherapy treatment among women diagnosed with DCIS in the NIH-AARP Diet and Health Study

Maeve Mullooly, Diana R. Withrow, Rochelle E. Curtis, Shaoqi Fan, Linda M. Liao, Ruth M. Pfeiffer, Amy Berrington de González, Gretchen L. Gierach

18.10.2019 | Epidemiology | Ausgabe 2/2020

Body mass index and risk of breast cancer molecular subtypes in Korean women: a case–control study

Seok Hun Jeong, Yoonsuk An, Choonghyun Ahn, Boyoung Park, Min Hyuk Lee, Dong-Young Noh, Sue K. Park

19.10.2019 | Epidemiology | Ausgabe 2/2020

Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults

Hiten Naik, Bonnie Leung, Janessa Laskin, Melanie McDonald, Amirrtha Srikanthan, Jonn Wu, Alan Bates, Cheryl Ho

24.10.2019 | Epidemiology | Ausgabe 2/2020 Open Access

Patient-reported cosmetic satisfaction and the long-term association with quality of life in irradiated breast cancer patients

M. C. T. Batenburg, M. L. Gregorowitsch, W. Maarse, A. Witkamp, D. A. Young-Afat, A. Braakenburg, A. Doeksen, T. van Dalen, M. Sier, E. J. P. Schoenmaeckers, C. H. van Gils, H. J. G. D. van den Bongard, H. M. Verkooijen, the UMBRELLA study group

31.10.2019 | Epidemiology | Ausgabe 2/2020

Association of depression and anxiety disorder with the risk of mortality in breast cancer: A National Health Insurance Service study in Korea

Eun-Jung Shim, Jong Won Lee, Jihyoung Cho, Hong Kyu Jung, Nam Hyoung Kim, Jung Eun Lee, Junwon Min, Woo Chul Noh, Sung-Hwan Park, Yoo Seok Kim

06.11.2019 | Epidemiology | Ausgabe 2/2020

The synergistic effect between adult weight changes and CYP24A1 polymorphisms is associated with pre- and postmenopausal breast cancer risk

Shang Cao, Feiran Wei, Jinyi Zhou, Zheng Zhu, Wei Li, Ming Wu

07.11.2019 | Epidemiology | Ausgabe 2/2020

Flat epithelial atypia: are we being too aggressive?

Ashley DiPasquale, Sveta Silverman, Erene Farag, Lashan Peiris

28.09.2019 | Rebuttal letter | Ausgabe 2/2020

Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism”

Glauco Akelinghton Freire Vitiello, Marla Karine Amarante, Bruna Karina Banin-Hirata, Clodoaldo Zago Campos, Karen Brajão de Oliveira, Roberta Losi-Guembarovski, Maria Angelica Ehara Watanabe

26.10.2019 | Correction | Ausgabe 2/2020

Correction to: The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1

Lufeng Zheng, Xiaoman Li, Yi Gu, Xiaobo Lv, Tao Xi

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.